Alcoholic liver disease, which ranges from mild disease to alcoholic hepatitis and cirrhosis,
is a leading cause of morbidity and mortality worldwide. Alcohol intake can lead to changes …

The rapid scientific interest in gut microbiota (GM) has coincided with a global increase in
the prevalence of infectious and non-infectivous liver diseases. GM, which is also called “the …

Although faecal microbiota transplantation (FMT) has a well-established role in the treatment
of recurrent Clostridioides difficile infection (CDI), its widespread dissemination is limited by …

Fecal microbiota transplantation (FMT) has become a highly effective bacteriotherapy for
recurrent Clostridium difficile infection. Meanwhile the efficacy of FMT for treating chronic …

Hepatic encephalopathy (HE) can cause major morbidity despite standard of care (SOC;
rifaximin/lactulose). Fecal microbial transplant (FMT) enemas postantibiotics are safe, but …

Fecal microbiota transplantation (FMT) is a well-established treatment for recurrent
Clostridioides difficile infection. FMT has become a more readily available and useful new …

The human gut is home to a large and diverse microbial community, comprising about 1,000
bacterial species. The gut microbiota exists in a symbiotic relationship with its host, playing a …

Fecal microbiota transplantation (FMT) is an infusion in the colon, or the delivery through the
upper gastrointestinal tract, of stool from a healthy donor to a recipient with a disease …

Alcohol-related liver disease is associated with significant changes in gut microbial
composition. The transmissibility of ethanol-induced liver disease has been demonstrated …

Background Faecal microbiota transplantation (FMT) has shown promise in alleviating the
symptoms of irritable bowel syndrome (IBS); however, controlled data on this technique are …